# Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial

> **NCT07269509** · NA · NOT_YET_RECRUITING · sponsor: **Renmin Hospital of Wuhan University** · enrollment: 276 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **PROCEDURE:** Basic Intratonsillar Immunotherapy (ITIT)
- **PROCEDURE:** Strengthen Intratonsillar Immunotherapy (ITIT)

## Key facts

- **NCT ID:** NCT07269509
- **Lead sponsor:** Renmin Hospital of Wuhan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-02-28
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269509, "Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07269509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*